Zobrazeno 1 - 10
of 348
pro vyhledávání: '"RICHARD M. BERGENSTAL"'
Autor:
Mary Johnson, Richard M Bergenstal, Roy W Beck, Anders L Carlson, Zoey Li, Elizabeth Norton, Sean Dunnigan, Matthew Banfield, Katie J Krumwiede, Judy R Sibayan, Peter Calhoun, Celeste Durnwald
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 3 (2024)
Introduction To characterize glucose levels during uncomplicated pregnancies, defined as pregnancy with a hemoglobin A1c 120 mg/dL (6.7 mmol/L) was 11%, and median per cent time >140 mg/dL (7.8 mmol/L) was 2.5%. Mean post-prandial peak glucose was 12
Externí odkaz:
https://doaj.org/article/b9e14acf68e64e6ab183bf0af5fd5097
Autor:
Elizabeth R Seaquist, Lawrence S Phillips, Alokananda Ghosh, Chelsea Baker, Richard M Bergenstal, Jill P Crandall, Robin S Goland, Michaela R Gramzinski, Sophia H Hox, Daniel S Hsia, Mary L Johnson, John M Lachin, Philip Raskin, Willy M Valencia, Andrea H Waltje, Naji Younes, GRADE Research Group
Publikováno v:
PLoS ONE, Vol 19, Iss 11, p e0309907 (2024)
ObjectiveHypoglycemia is a major concern in type 2 diabetes (T2DM), but little is known about its likelihood compared across common therapies. We compared the likelihood of hypoglycemia among metformin-treated patients with T2DM randomized to the add
Externí odkaz:
https://doaj.org/article/544ac5ac4b89417bb65554c229991ecc
Autor:
Roger Mazze, Richard M. Bergenstal, Robert Cuddihy, Ellie S. Strock, Amy Criego, Oded Langer, Gregg Simonson, Margaret A. Powers
This new edition of the successful Staged Diabetes Management will again address the prominent issues of primary care diabetes management based on the International Diabetes Center's'Staged Diabetes Management'program, which it advocates as part of i
Publikováno v:
eLife, Vol 10 (2021)
Laboratory HbA1c does not always predict diabetes complications and our aim was to establish a glycaemic measure that better reflects intracellular glucose exposure in organs susceptible to complications. Six months of continuous glucose monitoring d
Externí odkaz:
https://doaj.org/article/61914c6109ee47a8a9e12467d7fdc9e8
Publikováno v:
Diabetes Technology & Therapeutics. 25:324-328
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bb7764954288b51f47bbcc635351f71d
https://doi.org/10.1089/dia.2022.0544
https://doi.org/10.1089/dia.2022.0544
Autor:
Klemen, Dovc, Tadej, Battelino, Roy W, Beck, Judy, Sibayan, Ryan J, Bailey, Peter, Calhoun, Christine, Turcotte, Stuart, Weinzimer, Darja, Smigoc Schweiger, Revital, Nimri, Richard M, Bergenstal
Publikováno v:
Diabetes technologytherapeutics. 24(11)
The Medtronic advanced hybrid closed-loop (AHCL) and MiniMed™ 670G hybrid closed-loop (HCL) systems provide the option to temporarily increase the glucose target to 150 mg/dL (8.3 mmol/L). This analysis investigated the efficacy of the AHCL compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fa1bbb108d5493a3f5026cd19ac079a
https://pubmed.ncbi.nlm.nih.gov/35848991
https://pubmed.ncbi.nlm.nih.gov/35848991
Autor:
Maliha Khan, Naila Wahid, Taylor Musser, Richard M. Bergenstal, Osagie Ebekozien, Kenneth Snow, Kate Thomas, Christel Aprigliano
Publikováno v:
The Science of Diabetes Self-Management and Care. 49:112-125
Purpose The purpose of this research is to develop a set of continuous glucose monitoring (CGM)-related measure concepts to be tested in a health care system. Existing measures assessing the quality of diabetes care do not include modern approaches t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b921feb55b0a5da2e3e65f12a10f4a7
https://doi.org/10.1177/26350106231163518
https://doi.org/10.1177/26350106231163518
Autor:
Ronald M. Goldenberg, Vanita R. Aroda, Liana K. Billings, Anders Meller Donatsky, Marie Frederiksen, David C. Klonoff, Balamurali Kalyanam, Richard M. Bergenstal
Publikováno v:
Diabetes Therapy. 14:915-924
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::45af61bd5dc99f54b3f3a01f59686e7d
https://doi.org/10.1007/s13300-023-01389-2
https://doi.org/10.1007/s13300-023-01389-2
Publikováno v:
Diabetes Technology & Therapeutics. 25:157-160
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1f9556e647fcacdd66dd934abba69fa7
https://doi.org/10.1089/dia.2022.0462
https://doi.org/10.1089/dia.2022.0462
Autor:
Maamoun Salam, Ryan Bailey, Peter Calhoun, Janet B. McGill, Richard M. Bergenstal, David Price, Roy W. Beck
Publikováno v:
Diabetes Technology & Therapeutics. 25:178-185
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::951991db9a1a67ab75ee629cb2804482
https://doi.org/10.1089/dia.2022.0387
https://doi.org/10.1089/dia.2022.0387